Navigation Links
DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
Date:10/20/2011

s become a significant medical problem in hospitals, long-term care facilities and in the community. CDAD is a serious illness resulting from infection of the inner lining of the colon by C. difficile bacteria, which produce toxins that cause inflammation of the colon, severe diarrhea and, in the most serious cases, death. Patients typically develop CDAD from the use of broad-spectrum antibiotics that disrupt normal gastrointestinal (gut) flora, possibly allowing C. difficile bacteria to flourish. Older patients in particular are at risk for CDAD, potentially because of a weakened immune system or the presence of underlying disease. Approximately two-thirds of CDAD patients are 65 years of age or older. Historically, approximately 20% to 30% of CDAD patients who initially respond to treatment experience a clinical recurrence.

IDSA 2011

The 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) brings together physicians, scientists, and other health care professionals involved in research, patient care, public health, disease prevention, and education in the field of infectious diseases. The meeting showcases the latest news in the field of infectious diseases with emphasis on contemporary trends, including emerging infections, new diagnostic and therapeutic advances. IDSA 2011 takes place October 20-23 at the Boston Exhibition and Convention Center in Boston, Massachusetts. For more information, visit www.idsa2011.org.

About Optimer

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer has developed and commercialized DIFICID™ (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adults 18 years of age or older with Clostridium diffi
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
2. Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
3. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
4. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
5. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
6. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
7. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
8. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
9. Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
10. Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy
11. Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... "the Company"), a specialty pharmaceutical company focused on pharmaceuticals ... at the 27th Annual ROTH Conference, which will take ... in Dana Point, California . Management,s ... 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) in ...
(Date:3/3/2015)... , March 3, 2015  Web Industries, ... manufacturing services in the Medical Device, Advanced Composites, ... been named a 3M Medical Specialties Preferred Converter ... status will allow companies to streamline their supply ... of contact for 3M materials, intermediate converting services, ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... of the "Global Ultrasound Equipment Market 2015-2019" ... The Global Ultrasound Equipment market to ... period 2014-2019 Ultrasound equipment are used ... systems are extensively used by cardiologists, radiologists, surgeons, ...
Breaking Medicine Technology:Web Industries Receives 3M Preferred Converter Status 2Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... 4, 2011 PAREXEL International Corporation (Nasdaq: PRXL ... Morgan Healthcare Conference in San Francisco.  Josef von Rickenbach, Chairman ... PAREXEL at 8:30 a.m. PT on Thursday, January 13, 2011. ... available through the "Investors" section of PAREXEL,s website ...
... LAKES, N.J., Jan. 3, 2011 Medco Health Solutions, Inc. ... Snow Jr., is scheduled to present at the following healthcare ... The Goldman Sachs Healthcare CEOs Unscripted conference taking place in ... January 6, 2011 at 8:45 a.m. ET; ...
Cached Medicine Technology:PAREXEL International to Present at J.P. Morgan Healthcare Conference 2Medco CEO to Present at Upcoming Healthcare Conferences 2
(Date:3/3/2015)... 2015 Today, Steve Weatherford, current New ... wide receiver, announced the donation of their brains to ... Injury Awareness Month. In an effort to raise awareness ... of brain health, Rice and Weatherford spoke of their ... to make brain health a priority to avoid the ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles criminal ... recently spoke on the radio to give his insights into ... Independent Journal Review radio show “The Right Mics” chose Chambers ... and now as a criminal defense attorney would provide him ... and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... The human augmentation market is mainly driven by ... augmentation sector is predicted to outpace the in-built augmentation ... , The eye-wear sector dominates the North American ... new products launches in the region. Furthermore, strong economy ... well as the rising demand for advantageous products in ...
(Date:3/3/2015)... While it is clear that the ... young Canadian drivers are signing up to UBI policies, ... to be enticed. Due to current regulations, the application ... form. Its full capability is starting to be ... maintenance, emergency breakdown services are at the top of ...
(Date:3/3/2015)... NY (PRWEB) March 03, 2015 ... allege a metal-on-metal version of the artificial hip ... complications continue to move forward in the federal ... District of Texas. According to the most recent ... March 2, 2015, 7,350 Pinnacle hip replacement lawsuits ...
Breaking Medicine News(10 mins):Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4
... exposed as a drug addict with suicidal tendencies by his ... Kaylee feels that her grandfather would be heartbroken if he ... Gable, now. , ,She said: "My father is dying ... were alive today it would break his heart to see ...
... things and accepts them, although medical transcription is not so popular ... papers and are not well stocked in most cases. It is ... ,In contrast, in the US, medical case files are dictated by ... the US is well established. It is more than two decades ...
... Clinical Endocrinologists (AACE) Fifteenth Annual Meeting and Clinical Congress ... April 26-30 will discuss important benefits //of vitamin D ... ,Vitamin D has been in the ... disease has been attributed to it. Recent studies have ...
... features of the heart muscle could be used to ... is linked to a lethal, inherited heart condition // ... of Mayo’s HCM Clinic and co-lead investigator of the ... test was only able to detect this quirk about ...
... Brachytherapy, which is touted as the best and latest ... Sydney's Mater Hospital Radiotherpahy Department.// ,It is ... set to improve results with fewer side effects. ... the southern hemisphere, bringing together image-enhancing technology that builds ...
... Seattle scientists are planning to study the Major Histocompatibility Complex ... method for doing the same.// MHC is a large region, ... genes, the HLA genes governs tissue type and participate in ... governing susceptibility to autoimmune diseases or cancer. The MHC is ...
Cached Medicine News:Health News:Rising in career top charts is Medical transcription 2Health News:Unraveling the Secrets of MHC in Human Genome 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: